PetMed Express Files 8-K/A Amendment
Ticker: PETS · Form: 8-K/A · Filed: Dec 18, 2024 · CIK: 1040130
| Field | Detail |
|---|---|
| Company | Petmed Express Inc (PETS) |
| Form Type | 8-K/A |
| Filed Date | Dec 18, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, sec-filing
Related Tickers: PETS
TL;DR
PETS filed an 8-K/A on Dec 18th, amending a Dec 3rd report. No new info provided.
AI Summary
PetMed Express, Inc. filed an 8-K/A on December 18, 2024, to amend a previous filing related to events on December 3, 2024. The filing pertains to financial statements and exhibits, with no specific new financial details or material events disclosed in the provided text.
Why It Matters
This filing is an amendment to a previous report, indicating a correction or addition to information previously submitted to the SEC, though the specific nature of the amendment is not detailed here.
Risk Assessment
Risk Level: low — This is a routine amendment filing (8-K/A) that does not appear to disclose new material information or changes in the company's financial status.
Key Players & Entities
- PETMED EXPRESS INC (company) — Registrant
- December 3, 2024 (date) — Earliest event date
- December 18, 2024 (date) — Filing date
- 420 South Congress Avenue, Delray Beach, Florida 33445 (address) — Principal executive offices
FAQ
What is the purpose of this 8-K/A filing?
This 8-K/A filing is an amendment to a previous report, intended to correct or supplement information previously filed with the SEC.
What is the date of the earliest event reported?
The earliest event reported is December 3, 2024.
When was this 8-K/A filing submitted?
This 8-K/A filing was submitted on December 18, 2024.
What is the company's principal executive office address?
The company's principal executive office is located at 420 South Congress Avenue, Delray Beach, Florida 33445.
Does this filing disclose any new material financial information?
Based on the provided text, this 8-K/A filing is primarily for amending previous information and does not appear to disclose new material financial information.
Filing Stats: 770 words · 3 min read · ~3 pages · Grade level 11.5 · Accepted 2024-12-18 16:28:49
Key Financial Figures
- $0.001 — he Company's preferred stock, par value $0.001 per share, designated as Series A Junio
Filing Documents
- pets-20241203.htm (8-K/A) — 32KB
- pets-articlesofamendmentto.htm (EX-3.1) — 44KB
- pets-shareholderrightsagre.htm (EX-4.1) — 365KB
- 0001040130-24-000126.txt ( ) — 641KB
- pets-20241203.xsd (EX-101.SCH) — 2KB
- pets-20241203_lab.xml (EX-101.LAB) — 22KB
- pets-20241203_pre.xml (EX-101.PRE) — 13KB
- pets-20241203_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 3.1* Articles of Amendment to the Amended and Restated Articles of Incorporation, dated December 3, 2024 (incorporated by reference to Exhibit 3.1 to the Company's Registration Statement on Form 8-A, filed with the Securities and Exchange Commission on December 3, 2024). 4.1* Rights Agreement, dated December 3, 2024, by and between the Company and Continental Stock Transfer & Trust Company, as rights agent (which includes the Form of Right Certificate as Exhibit B thereto) (incorporated by reference to Exhibit 4.1 to the Company's Registration Statement on Form 8-A, filed with the Securities and Exchange Commission on December 3). 99.1# Press Release issued by the Company on December 3, 2024. 104# Cover Page Interactive Data File (formatted as Inline XBRL) *Filed Herewith #Filed as an exhibit to the Initial Report * * * 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 18, 2024 PETMED EXPRESS, INC. By: /s/ Sandra Compos Name: Sandra Campos Title: Chief Executive Officer and President 3